Literature DB >> 3910773

Captopril in the treatment of hypertension in type I and type II diabetic patients.

G Gambaro, F Morbiato, E Cicerello, M Del Turco, L Sartori, A D'Angelo, G Crepaldi.   

Abstract

Ten type I and 10 type II hypertensive diabetic patients were treated for 12 weeks with captopril (50 mg twice daily). Good control of blood pressure was achieved without any significant adverse effect on carbohydrate metabolism or renal haemodynamics and without evidence of glomerular or tubular damage.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3910773

Source DB:  PubMed          Journal:  J Hypertens Suppl        ISSN: 0952-1178


  7 in total

Review 1.  Diabetic nephropathy. Its relationship to hypertension and means of pharmacological intervention.

Authors:  T Baba; S Neugebauer; T Watanabe
Journal:  Drugs       Date:  1997-08       Impact factor: 9.546

Review 2.  ACE inhibitors in the prevention and therapy of diabetic nephropathy. What is their role?

Authors:  C C Kelleher
Journal:  Drugs       Date:  1990-05       Impact factor: 9.546

Review 3.  Recent Advances in Pharmacological Management of Hypertension in Diabetic Patients with Nephropathy : Effects of Antihypertensive Drugs on Kidney Function and Insulin Sensitivity.

Authors:  Tsuneharu Baba; Takashi Ishizaki
Journal:  Drugs       Date:  1992-04       Impact factor: 9.546

Review 4.  Captopril. An update of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in hypertension and congestive heart failure.

Authors:  R N Brogden; P A Todd; E M Sorkin
Journal:  Drugs       Date:  1988-11       Impact factor: 9.546

5.  Angiotensin-converting enzyme (ACE) inhibition. Therapeutic option for diabetic hypertensive patients.

Authors:  M T Zanella; B J Salgado; O Kohlmann; A B Ribeiro
Journal:  Drugs       Date:  1990       Impact factor: 9.546

6.  Effect of chronic treatment with enalapril on glucose tolerance and serum insulin in non-insulin-resistant Japanese patients with essential hypertension.

Authors:  T Baba; T Kodama; T Ishizaki
Journal:  Eur J Clin Pharmacol       Date:  1993       Impact factor: 2.953

7.  Swiss hypertension treatment programme with verapamil and/or enalapril in diabetic patients.

Authors:  C Ferrier; P Ferrari; P Weidmann; U Keller; C Beretta-Piccoli; W F Riesen
Journal:  Drugs       Date:  1992       Impact factor: 9.546

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.